Diabetic Kidney Disease Collaborative (DKD-C)

This new online learning module is intended for individuals with chronic kidney disease and diabetes, and the healthcare providers who care for them.

This module was developed under the leadership of Patrick O. Gee, Sr., PhD., Steering Committee member and patient advocate.

NOTE: Upon completion of this module and the evaluation, you will have the opportunity to print a Certificate of Attendance. Your input on the evaluation will assist ASN in updating this resource in the future.

Diabetic kidney disease (DKD) is the most frequent cause of kidney failure, accounting for half of all cases worldwide. DKD has enormous personal and societal consequences in terms of worsened quality of life, mortality, and health care costs. Access to care and implementation of breakthrough therapies for DKD can save millions of lives by preventing kidney failure, cardiovascular events, and premature death. In this CJASN article, the DKD-C Task Force calls for coordinated patient-centered care models incorporating these therapies for all people living with DKD.

The American Society of Nephrology’s (ASN’s) Diabetic Kidney Disease Collaborative (DKD-C) conducted the second in a series of three strategy conferences on April 20, 2021. Conference participants strategized on how nephrologists and primary care physicians can work together to ensure the implementation of new diabetic kidney disease therapies, such as SGLT2 inhibitors.